Adaptimmune Therapeutics (ADAP) Stocktwits Mentions Statistics 2025

2,621 23.2%

1W 18.7% 1M 28.9% 3M 5249%

Est. daily mentions on Stocktwits.

Similar companies

Company		Stocktwits Mentions
	Amgen AMGN	31 6.9%
	Gilead Sciences GILD	65 3%
	Catalyst Pharmaceuticals CPRX	8 11.1%
	Inovio Pharmaceuticals INO	115 0%
	Anavex Life Sciences AVXL	445 25.2%

Month over Month

Est. daily mentions on Stocktwits.

Sep 2025	1,395	54.2%
Aug 2025	905	834.1%
Jul 2025	97	129.7%
Jun 2025	42	18.5%
May 2025	36

How often is Adaptimmune Therapeutics mentioned on StockTwits?

Adaptimmune Therapeutics was mentioned an estimated 2,621 times in discussions on StockTwits yesterday.

Analyzing Stocktwits Mentions, how is Adaptimmune Therapeutics performing compared to its industry peers?

Compared to its peers, Adaptimmune Therapeutics ranks in the 54th percentile when it comes to Stocktwits Mentions.

What does a high frequency of StockTwits mentions indicate for Adaptimmune Therapeutics' market sentiment?

A high frequency of mentions on StockTwits for Adaptimmune Therapeutics could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Adaptimmune Therapeutics' stock, potentially signaling bullish or bearish trends based on the context of the discussions.

How often does AltIndex update information on Adaptimmune Therapeutics' mentions on StockTwits?

AltIndex updates the data on Adaptimmune Therapeutics' mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Adaptimmune Therapeutics' on the platform.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.